Insider Selling: Dolby Laboratories (NYSE:DLB) CFO Sells 4,895 Shares of Stock

Key Points

  • Dolby Laboratories CFO Robert Park sold 4,895 shares on May 12 at an average price of $56.68, totaling about $277,449. After the sale, he still held 81,490 shares, representing a 5.67% reduction in his stake.
  • The company recently beat quarterly expectations, reporting EPS of $1.37 versus the $1.31 consensus and revenue of $395.63 million, up 7% year over year. Dolby also issued FY2026 and Q3 2026 guidance above current-year analyst expectations.
  • Dolby announced a quarterly dividend of $0.36 per share, payable on May 20, for an annualized yield of 2.6%. Analysts currently rate the stock a “Moderate Buy” with a consensus price target of $90.75.

Dolby Laboratories (NYSE:DLB - Get Free Report) CFO Robert Park sold 4,895 shares of the company's stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $56.68, for a total transaction of $277,448.60. Following the transaction, the chief financial officer owned 81,490 shares in the company, valued at $4,618,853.20. The trade was a 5.67% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Dolby Laboratories Price Performance

Dolby Laboratories stock opened at $54.75 on Friday. The firm has a market capitalization of $5.18 billion, a P/E ratio of 21.64 and a beta of 0.86. Dolby Laboratories has a 1-year low of $53.45 and a 1-year high of $77.59. The company's 50-day moving average is $61.32 and its 200 day moving average is $63.85.

Dolby Laboratories (NYSE:DLB - Get Free Report) last issued its quarterly earnings results on Thursday, April 30th. The electronics maker reported $1.37 earnings per share for the quarter, topping the consensus estimate of $1.31 by $0.06. Dolby Laboratories had a return on equity of 11.47% and a net margin of 17.85%.The firm had revenue of $395.63 million for the quarter, compared to the consensus estimate of $385.80 million. During the same period in the prior year, the business posted $1.34 earnings per share. The company's revenue for the quarter was up 7.0% on a year-over-year basis. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. Research analysts anticipate that Dolby Laboratories will post 3.22 earnings per share for the current fiscal year.

Dolby Laboratories Announces Dividend




The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 20th. Stockholders of record on Tuesday, May 12th will be paid a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date of this dividend is Tuesday, May 12th. Dolby Laboratories's payout ratio is currently 56.92%.

Institutional Trading of Dolby Laboratories

Institutional investors and hedge funds have recently made changes to their positions in the company. First Horizon Corp purchased a new stake in Dolby Laboratories in the third quarter worth about $25,000. Hantz Financial Services Inc. increased its position in Dolby Laboratories by 166.7% during the 3rd quarter. Hantz Financial Services Inc. now owns 352 shares of the electronics maker's stock valued at $25,000 after purchasing an additional 220 shares during the period. Rothschild Investment LLC raised its holdings in shares of Dolby Laboratories by 4,046.7% in the 3rd quarter. Rothschild Investment LLC now owns 622 shares of the electronics maker's stock valued at $45,000 after purchasing an additional 607 shares in the last quarter. Fifth Third Bancorp lifted its position in shares of Dolby Laboratories by 34.7% in the 4th quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker's stock worth $48,000 after purchasing an additional 192 shares during the period. Finally, Migdal Insurance & Financial Holdings Ltd. purchased a new stake in shares of Dolby Laboratories in the 3rd quarter worth approximately $50,000. 58.56% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research firms recently commented on DLB. Barrington Research reaffirmed an "outperform" rating and issued a $90.00 price target on shares of Dolby Laboratories in a research note on Monday, April 27th. Rosenblatt Securities restated a "buy" rating and issued a $85.00 target price on shares of Dolby Laboratories in a research note on Friday, January 30th. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Dolby Laboratories in a research report on Friday, March 27th. Finally, Wall Street Zen downgraded shares of Dolby Laboratories from a "buy" rating to a "hold" rating in a research note on Saturday, January 31st. Three investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $90.75.

Check Out Our Latest Stock Report on DLB

Dolby Laboratories Company Profile

(Get Free Report)

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company's core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby's licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.

Featured Stories

Insider Buying and Selling by Quarter for Dolby Laboratories (NYSE:DLB)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Dolby Laboratories?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Dolby Laboratories and related companies.
From Our Partners
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles